This study if for patients with recurrent glioblastomas. It is looking at standard of care treatment (Lomustine) vs Anti-LAG-3 and Anti-PD-L1 Blockade.
Contact phone
Tracy Bellefeuil | (517) 364-2835
Contact email
[email protected]
Principal investigator
Dr. Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Glioblastoma
Webform